Discover Lichen China Limited's transformative 6-K filing, detailing capital increases, name change, and shareholder approvals. Key insights into the company's strategic future.
Explore Golden Heaven Group Holdings Ltd.'s February 2025 6-K report detailing the EGM, share capital increase, and strategic consolidation plans to enhance growth and stability.
Explore Universe Pharmaceuticals Inc.'s 6-K report detailing the February 2025 shareholder meeting agenda, including revised share consolidation proposals and important notices.
Explore Evaxion Biotech A/S's January 2025 Form 6-K filing revealing a DKK 11.47M share capital increase and warrant exercises. Key details on compliance and growth strategies.
Vodafone Group Plc filed a Form 6-K/A on Jan 3, 2025, amending its issued share capital & total voting rights. Stay informed on key regulatory compliance and equity structure changes.
Explore Ascendis Pharma A/S's December 2024 financial report detailing warrant exercises, capital structure changes, and share issuance impacts on shareholders.
Arqit Quantum Inc. reports on its EGM held on December 18, 2024, where shareholders approved a significant increase in authorized share capital, reflecting strong support for growth initiatives.
On December 17, 2024, Solowin Holdings held an EGM, achieving quorum to approve a significant re-designation of share capital and amendments to corporate governance.
TORM plc's December 2024 Form 6-K reveals a capital increase via 7,468 Class A shares from RSU exercises. Details included in the December 18 press release.